Ferritin as a potential disease marker in patients with bipolar disorder

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Ferritin as a potential disease marker in patients with bipolar disorder. / Munkholm, Klaus; Jacoby, Anne Sophie; Vinberg, Maj; Kessing, Lars Vedel.

In: Journal of Affective Disorders, Vol. 332, 2023, p. 247-253.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Munkholm, K, Jacoby, AS, Vinberg, M & Kessing, LV 2023, 'Ferritin as a potential disease marker in patients with bipolar disorder', Journal of Affective Disorders, vol. 332, pp. 247-253. https://doi.org/10.1016/j.jad.2023.04.006

APA

Munkholm, K., Jacoby, A. S., Vinberg, M., & Kessing, L. V. (2023). Ferritin as a potential disease marker in patients with bipolar disorder. Journal of Affective Disorders, 332, 247-253. https://doi.org/10.1016/j.jad.2023.04.006

Vancouver

Munkholm K, Jacoby AS, Vinberg M, Kessing LV. Ferritin as a potential disease marker in patients with bipolar disorder. Journal of Affective Disorders. 2023;332:247-253. https://doi.org/10.1016/j.jad.2023.04.006

Author

Munkholm, Klaus ; Jacoby, Anne Sophie ; Vinberg, Maj ; Kessing, Lars Vedel. / Ferritin as a potential disease marker in patients with bipolar disorder. In: Journal of Affective Disorders. 2023 ; Vol. 332. pp. 247-253.

Bibtex

@article{f88c68a07f484a19ab53ef1218be0072,
title = "Ferritin as a potential disease marker in patients with bipolar disorder",
abstract = "Background: Low-grade inflammation and oxidative stress have been implicated as potential pathophysiological processes in bipolar disorder, but the underlying mechanism is unknown. Ferritin is a marker of iron stores and involved in redox processes and inflammation but its role in bipolar disorder is unclear. Methods: We investigated the possible association of increased plasma ferritin levels and bipolar disorder. We pooled two studies using similar longitudinal repeated measures designs and included 330 blood- and urinary samples from 95 patients with bipolar disorder across all affective states and 84 samples from 84 healthy control individuals. Plasma ferritin was measured along with multiple blood inflammatory markers and urinary markers of oxidatively generated damage to DNA and RNA. Results: Plasma ferritin levels, adjusting for multiple demographical- and lifestyle variables, did not differ between patients with bipolar disorder compared with healthy control individuals (b = 1.09, 95 % CI: 0.86 to 1.39, p = 0.49). Within patients with bipolar disorder ferritin levels were higher in a depressed state compared with euthymia (b = 1.12, 95 % CI: 1.01 to 1.24, p < 0.04), and ferritin levels were positively associated with Interleukin-18 blood levels and urinary levels of 8-oxodG. Limitations: Patients with bipolar disorder received medication which could potentially influence iron metabolism. Conclusion: Elevated ferritin levels in depressed patients with bipolar disorder may point to a role for iron metabolism in bipolar disorder pathophysiology, and potentially as a biomarker, linking low-grade inflammation with redox biology and the well-known increased risk of medical comorbidity and reduced life expectancy.",
keywords = "Bipolar disorder, Ferritin, Inflammation, iron, Oxidative stress",
author = "Klaus Munkholm and Jacoby, {Anne Sophie} and Maj Vinberg and Kessing, {Lars Vedel}",
note = "Publisher Copyright: {\textcopyright} 2023 Elsevier B.V.",
year = "2023",
doi = "10.1016/j.jad.2023.04.006",
language = "English",
volume = "332",
pages = "247--253",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Ferritin as a potential disease marker in patients with bipolar disorder

AU - Munkholm, Klaus

AU - Jacoby, Anne Sophie

AU - Vinberg, Maj

AU - Kessing, Lars Vedel

N1 - Publisher Copyright: © 2023 Elsevier B.V.

PY - 2023

Y1 - 2023

N2 - Background: Low-grade inflammation and oxidative stress have been implicated as potential pathophysiological processes in bipolar disorder, but the underlying mechanism is unknown. Ferritin is a marker of iron stores and involved in redox processes and inflammation but its role in bipolar disorder is unclear. Methods: We investigated the possible association of increased plasma ferritin levels and bipolar disorder. We pooled two studies using similar longitudinal repeated measures designs and included 330 blood- and urinary samples from 95 patients with bipolar disorder across all affective states and 84 samples from 84 healthy control individuals. Plasma ferritin was measured along with multiple blood inflammatory markers and urinary markers of oxidatively generated damage to DNA and RNA. Results: Plasma ferritin levels, adjusting for multiple demographical- and lifestyle variables, did not differ between patients with bipolar disorder compared with healthy control individuals (b = 1.09, 95 % CI: 0.86 to 1.39, p = 0.49). Within patients with bipolar disorder ferritin levels were higher in a depressed state compared with euthymia (b = 1.12, 95 % CI: 1.01 to 1.24, p < 0.04), and ferritin levels were positively associated with Interleukin-18 blood levels and urinary levels of 8-oxodG. Limitations: Patients with bipolar disorder received medication which could potentially influence iron metabolism. Conclusion: Elevated ferritin levels in depressed patients with bipolar disorder may point to a role for iron metabolism in bipolar disorder pathophysiology, and potentially as a biomarker, linking low-grade inflammation with redox biology and the well-known increased risk of medical comorbidity and reduced life expectancy.

AB - Background: Low-grade inflammation and oxidative stress have been implicated as potential pathophysiological processes in bipolar disorder, but the underlying mechanism is unknown. Ferritin is a marker of iron stores and involved in redox processes and inflammation but its role in bipolar disorder is unclear. Methods: We investigated the possible association of increased plasma ferritin levels and bipolar disorder. We pooled two studies using similar longitudinal repeated measures designs and included 330 blood- and urinary samples from 95 patients with bipolar disorder across all affective states and 84 samples from 84 healthy control individuals. Plasma ferritin was measured along with multiple blood inflammatory markers and urinary markers of oxidatively generated damage to DNA and RNA. Results: Plasma ferritin levels, adjusting for multiple demographical- and lifestyle variables, did not differ between patients with bipolar disorder compared with healthy control individuals (b = 1.09, 95 % CI: 0.86 to 1.39, p = 0.49). Within patients with bipolar disorder ferritin levels were higher in a depressed state compared with euthymia (b = 1.12, 95 % CI: 1.01 to 1.24, p < 0.04), and ferritin levels were positively associated with Interleukin-18 blood levels and urinary levels of 8-oxodG. Limitations: Patients with bipolar disorder received medication which could potentially influence iron metabolism. Conclusion: Elevated ferritin levels in depressed patients with bipolar disorder may point to a role for iron metabolism in bipolar disorder pathophysiology, and potentially as a biomarker, linking low-grade inflammation with redox biology and the well-known increased risk of medical comorbidity and reduced life expectancy.

KW - Bipolar disorder

KW - Ferritin

KW - Inflammation

KW - iron

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=85152443483&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2023.04.006

DO - 10.1016/j.jad.2023.04.006

M3 - Journal article

C2 - 37037316

AN - SCOPUS:85152443483

VL - 332

SP - 247

EP - 253

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -

ID: 370724049